Letter

Trial of thyroxine treatment for biochemically euthyroid patients has been approved

BMJ 1997; 315 doi: 10.1136/bmj.315.7120.1463 (Published 29 November 1997)
Cite this as: BMJ 1997;315:1463.1

This article has a correction

Please see: Reduction in use of temazepam is factor in deaths related to overdose

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

  1. E H McLaren, Consultant physiciana,
  2. C J G Kelly, Specialist registrar in endocrinologya,
  3. M A Pollock, Principal biochemista
  1. a Stobhill NHS Trust, Glasgow G21 3UW

    Editor—Skinner et al's suggestion that patients with symptoms of hypothyroidism and normal results of thyroid function tests might benefit from treatment with thyroxine1 received considerable publicity in our local evening newspaper. As a result, several patients were referred to our clinic.

    Since they complained of a considerable reduction in their quality of life, …

    Access to the full text of this article requires a subscription or payment

    Subscribe

    Article access

    Article access for 1 day

    Purchase this article for £20 $30 €32*

    The PDF version can be downloaded as your personal record

    * Prices do not include VAT

    Rapid responses

    THIS WEEK'S POLL

    BMJ most popular